| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.079 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.087 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |